Comment
doi: 10.1016/S1470-2045(13)70583-7.
Epub 2013 Dec 11.
Which bisphosphonate to treat bone metastases?
Affiliations
- PMID: 24332513
- DOI: 10.1016/S1470-2045(13)70583-7
Item in Clipboard
Comment
Which bisphosphonate to treat bone metastases?
Lancet Oncol.
2014 Jan.
No abstract available
Comment on
-
Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.Lancet Oncol. 2014 Jan;15(1):114-22. doi: 10.1016/S1470-2045(13)70539-4. Epub 2013 Dec 11. Lancet Oncol. 2014. PMID: 24332514 Clinical Trial.
Similar articles
-
Long interval zoledronic acid use in bone metastases.Lancet Oncol. 2017 Feb;18(2):e72. doi: 10.1016/S1470-2045(17)30019-0. Epub 2017 Jan 13. Lancet Oncol. 2017. PMID: 28089632 No abstract available.
-
[Zoledronic acid and bone pathology in the course of neoplasia. Part I].Tumori. 2005 Sep-Oct;91(5):22-6. doi: 10.1177/030089160509100524. Tumori. 2005. PMID: 16459649 Review. Italian. No abstract available.
-
Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer.Korean J Ophthalmol. 2017 Aug;31(4):368-369. doi: 10.3341/kjo.2017.0018. Epub 2017 Jun 23. Korean J Ophthalmol. 2017. PMID: 28682020 Free PMC article. No abstract available.
-
[Clinical study of bisphosphonates for bone metastasis in breast cancer].Nihon Rinsho. 2007 Nov 28;65 Suppl 9:352-5. Nihon Rinsho. 2007. PMID: 18161130 Review. Japanese. No abstract available.
-
Zoledronic acid in the treatment of metastatic breast cancer.Anticancer Drugs. 2014 Jan;25(1):1-7. doi: 10.1097/CAD.0000000000000020. Anticancer Drugs. 2014. PMID: 24100278 Review.
Cited by
-
Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer-induced bone loss.Br J Clin Pharmacol. 2019 Jun;85(6):1114-1124. doi: 10.1111/bcp.13852. Epub 2019 Feb 16. Br J Clin Pharmacol. 2019. PMID: 30601585 Free PMC article. Review.
-
Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?Int J Mol Sci. 2016 Aug 27;17(9):1415. doi: 10.3390/ijms17091415. Int J Mol Sci. 2016. PMID: 27618899 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
